We are live on
!
Find out more
Lord, Abbett & Co Portfolio holdings
AUM
$30.6B
1-Year Est. Return
57.44%
This Fund
S&P 500
This Quarter
Est. Return
-11.95%
1 Year Est. Return
+57.44%
3 Year Est. Return
+215.76%
5 Year Est. Return
+368.6%
10 Year Est. Return
+2,376.62%
AUM
$28.3B
AUM Growth
-$9.23B
(-25%)
Cap. Flow
-$5.59B
Cap. Flow
% of AUM
-19.76%
Top 10 Holdings %
Top 10 Hldgs %
17.15%
Holding
651
New
62
Increased
201
Reduced
214
Closed
94
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Elevance Health
ELV
|
+$97.8M |
| 2 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$95.6M |
| 3 |
Cheniere Energy
LNG
|
+$94.4M |
| 4 |
Visa
V
|
+$92.5M |
| 5 |
AstraZeneca
AZN
|
+$88.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SBNY
Signature Bank
SBNY
|
+$204M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$196M |
| 3 |
NVIDIA
NVDA
|
+$131M |
| 4 |
Alexandria Real Estate Equities
ARE
|
+$130M |
| 5 |
Marathon Petroleum
MPC
|
+$129M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.41% |
| 2 | Healthcare | 17.34% |
| 3 | Financials | 13.09% |
| 4 | Industrials | 10.79% |
| 5 | Consumer Discretionary | 7.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Allegion
ALLE
$13.5B
| $28.3M | 0.1% |
289,386
+47,513
| +20% | +$5.16M |
|
|
NAPA
252
DELISTED
The Duckhorn Portfolio, Inc.
NAPA
| $28M | 0.1% |
1,328,134
+333,885
| +34% | +$6.55M |
|
253
Cadence Design Systems
CDNS
$91.6B
| $27.9M | 0.1% |
186,030
+12,375
| +7% | +$1.87M |
|
254
Interparfums
IPAR
$4.07B
| $27.4M | 0.1% |
375,451
+12,902
| +4% | +$988K |
|
255
Walt Disney
DIS
$171B
| $27.4M | 0.1% |
+290,215
| New | +$32.2M |
|
256
TPG
TPG
$6.76B
| $27.2M | 0.1% |
1,135,867
+180,029
| +19% | +$4.86M |
|
257
Lumentum
LITE
$46.9B
| $26.8M | 0.09% |
337,879
+11,144
| +3% | +$952K |
|
258
Papa John's
PZZA
$1.01B
| $26.7M | 0.09% |
320,272
-104,656
| -25% | -$9.43M |
|
259
Bio-Techne
TECH
$11.2B
| $26.6M | 0.09% |
307,036
+576
| +0.2% | +$54K |
|
|
CERE
260
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $26.5M | 0.09% |
1,002,964
+273,114
| +37% | +$7.75M |
|
261
Cooper Companies
COO
$14.2B
| $26.2M | 0.09% |
334,828
+26,292
| +9% | +$2.33M |
|
262
Envista
NVST
$4.62B
| $25.9M | 0.09% |
672,699
-423,442
| -39% | -$17.8M |
|
263
Moelis & Co
MC
$4.85B
| $25.2M | 0.09% |
641,115
+15,588
| +2% | +$680K |
|
264
Jacobs Solutions
J
$16B
| $25.2M | 0.09% |
+239,403
| New | +$26.8M |
|
265
FTI Consulting
FCN
$5.14B
| $25.1M | 0.09% |
+138,781
| New | +$22.9M |
|
266
Dow Inc
DOW
$22B
| $25M | 0.09% |
484,245
+179,545
| +59% | +$11.5M |
|
267
Exelon
EXC
$48.1B
| $24.8M | 0.09% |
546,672
-53,328
| -9% | -$2.51M |
|
268
Charles River Laboratories
CRL
$11.3B
| $24.7M | 0.09% |
115,613
+9,072
| +9% | +$2.22M |
|
269
Procore
PCOR
$7.57B
| $24.6M | 0.09% |
541,234
+18,483
| +4% | +$908K |
|
|
CALY
270
Callaway Golf Company
CALY
$3.28B
| $24.5M | 0.09% |
1,202,155
-188,209
| -14% | -$4.05M |
|
271
Glacier Bancorp
GBCI
$6.36B
| $24.5M | 0.09% |
516,835
-102,961
| -17% | -$4.85M |
|
272
Sarepta Therapeutics
SRPT
$1.64B
| $24.3M | 0.09% |
323,931
+11,149
| +4% | +$820K |
|
273
Huntington Ingalls Industries
HII
$11B
| $24.2M | 0.09% |
+111,000
| New | +$23.4M |
|
274
W.R. Berkley
WRB
$28.1B
| $23.9M | 0.08% |
+525,000
| New | +$23.9M |
|
275
Cabot Corp
CBT
$4.72B
| $23.5M | 0.08% |
+368,995
| New | +$25.2M |
|
Similar funds
Lord, Abbett & Co's Q2 2022 Portfolio in Review
As of Q2 2022, Lord, Abbett & Co held 651 positions worth $28.3B, down 25% from $37.5B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Lord, Abbett & Co withdrew a net $5.59B in Q2 2022, closing 94 positions and reducing 214 holdings. Its most notable exit was Signature Bank, an estimated $204M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Lord, Abbett & Co opened a new position in Elevance Health worth $95.4M.
- Lord, Abbett & Co's largest Q2 2022 buy was Elevance Health: 197,668 shares worth $95.4M.
- Lord, Abbett & Co added most to Seagen Inc. Common Stock in Q2 2022, an estimated $95.6M increase.
- Lord, Abbett & Co's biggest Q2 2022 reduction was Alphabet (Google) Class A, cutting an estimated $196M.
- Lord, Abbett & Co fully exited Signature Bank in Q2 2022, selling an estimated $204M.
- Lord, Abbett & Co's ten largest holdings make up 17% of its $28.3B portfolio in Q2 2022.
- Lord, Abbett & Co opened 62 new positions and closed 94 in Q2 2022.
- Lord, Abbett & Co's portfolio value fell 25% quarter-over-quarter to $28.3B.
Based on Lord, Abbett & Co's 13F filing for Q2 2022, filed 12 Aug 2022.